Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
05 mei 2015 - 08:14
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to Present at Drug Design & Medicinal Chemistry Conference 2015
Bericht
Probiodrug to Present at Drug Design & Medicinal Chemistry Conference 2015
GTC 9th Drug Design & Medicinal Chemistry Conference, 5-6 May 2015, Berlin, Germany
HALLE/SAALE, Germany, 05 May 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, today announced that Ulrich Heiser, PhD, Director Medicinal Chemistry/CMC at Probiodrug AG has been invited to present at the GTC 9th Drug Design & Medicinal Chemistry Conference, taking place from May 5-6, 2015 in Berlin, Germany.
Gerelateerde downloads
Datum laatste update: 25 december 2025